top of page
Executive Spotlights

Baxter to sell biopharma unit for $4.25 billion

Deerfield, IL, May 8, 2023 (Reuters) -- Baxter International Inc. has agreed to sell its biopharma solutions unit to a private-equity group for $4.25 billion, with the proceeds being used to pay down debt from its acquisition of Hill-Rom Holdings. This comes as medical device manufacturers struggle with supply-chain shortages and increased costs due to the pandemic.


Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page